ASTRAZENECA PLC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge
SEC filing record 1 source field available
Fiscal year end
31 December
ASTRAZENECA PLC has filed 2,050 SEC EDGAR filings since 13 Mar 1995

SEC filing history

Showing 801-825 of 1,000 matching filings.

Per page
25
Current page
33
6-K File 001-11960

TOTAL VOTING RIGHTS

Filing date
01 Oct 2020
Reporting date
01 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTORATE CHANGE

Filing date
25 Sep 2020
Reporting date
25 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-11960

CERT filing

Filing date
24 Sep 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-11960

8-A12B

Filing date
24 Sep 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
25 File 001-11960

25

Filing date
24 Sep 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

LYNPARZA RECOMMENDED FOR APPROVAL IN THE EU BY CHMP FOR BRCA-MUTATED METASTATIC

Filing date
21 Sep 2020
Reporting date
21 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

LYNPARZARECOMMENDED FOR APPROVAL IN EU BY CHMP AS 1ST-LINE MAINTENANCE TREATMENT

Filing date
21 Sep 2020
Reporting date
21 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

TAGRISSO REDUCED THE RISK OF DISEASE RECURRENCE IN THE BRAIN BY 82% IN THE ADJUV

Filing date
21 Sep 2020
Reporting date
21 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ASTRAZENECA TO LIST US ADR EQUITY AND ALL US DEBT SECURITIES ON NASDAQ

Filing date
10 Sep 2020
Reporting date
10 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

FASENRA MET BOTH CO-PRIMARY ENDPOINTS OF REDUCED NASAL POLYP SIZE AND BLOCKAGE I

Filing date
10 Sep 2020
Reporting date
10 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

TOTAL VOTING RIGHTS

Filing date
01 Sep 2020
Reporting date
01 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

IMFINZI APPROVED IN EU FOR SMALL CELL LUNG CANCER

Filing date
01 Sep 2020
Reporting date
01 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

FARXIGA REDUCES CKD PROGRESSION AND RISK OF DEATH

Filing date
01 Sep 2020
Reporting date
01 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

PHASE I CLINICAL TRIAL INITIATED FOR MONOCLONAL ANTIBODY COMBINATION FOR THE PRE

Filing date
25 Aug 2020
Reporting date
25 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

IMFINZI APPROVED IN JAPAN FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG C

Filing date
21 Aug 2020
Reporting date
21 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

IMFINZI GRANTED FDA PRIORITY REVIEW FOR LESS-FREQUENT, FIXED-DOSE USE

Filing date
18 Aug 2020
Reporting date
18 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-11960

NYSE CERTIFICATION

Filing date
12 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-11960

FORM 8-A12B

Filing date
06 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

FORM 6-K

Filing date
06 Aug 2020
Reporting date
06 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B2 File 333-234586

FORM 424B2

Filing date
05 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ASTRAZENECA PRICES A $3BN BOND ISSUE

Filing date
04 Aug 2020
Reporting date
04 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-234586

FORM FWP

Filing date
04 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-240298

S-8

Filing date
03 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

TOTAL VOTING RIGHTS

Filing date
03 Aug 2020
Reporting date
03 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-234586

FORM FWP

Filing date
03 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .